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Abstract 
Excess superoxide (𝑂2
•−) and nitric oxide (NO•) forms peroxynitrite 
(ONOO−) during cardiac ischemia reperfusion (IR) injury, which in turn 
induces protein tyrosine nitration (tyr-N). Mitochondria are both a source of 
and target for ONOO−. Our aim was to identify specific mitochondrial proteins 
that display enhanced tyr-N after cardiac IR injury, and to explore whether 
inhibiting 𝑂2
•−/ONOO− during IR decreases mitochondrial protein tyr-N and 
consequently improves cardiac function. We show here that IR increased tyr-
N of 35 and 15 kDa mitochondrial proteins using Western blot analysis with 3-
nitrotyrosine antibody. Immunoprecipitation (IP) followed by LC–MS/MS 
identified 13 protein candidates for tyr-N. IP and Western blot identified and 
confirmed that the 35 kDa tyr-N protein is the voltage-dependent anion 
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channel (VDAC). Tyr-N of native cardiac VDAC with IR was verified on 
recombinant (r) VDAC with exogenous ONOO−. We also found that ONOO− 
directly enhanced rVDAC channel activity, and rVDAC tyr-N induced by 
ONOO− formed oligomers. Resveratrol (RES), a scavenger of 𝑂2
•−/ONOO−, 
reduced the tyr-N levels of both native and recombinant VDAC, while L-NAME, 
which inhibits NO• generation, only reduced tyr-N levels of native VDAC. 𝑂2
•− 
and ONOO− levels were reduced in perfused hearts during IR by RES and L-
NAME and this was accompanied by improved cardiac function. These results 
identify tyr-N of VDAC and show that reducing ONOO− during cardiac IR injury 
can attenuate tyr-N of VDAC and improve cardiac function. 
Keywords: Mitochondria, Protein tyrosine nitration, Cardiac injury, VDAC, 
ROS/RNS scavengers. 
1. Introduction 
Mitochondrial dysfunction during cardiac ischemia (I) and 
reperfusion (R) injury is associated with Ca2+ overload, excess 
emission of reactive oxygen species (ROS) [1–3] and reactive nitrogen 
species (RNS) [4,5] that can lead to deleterious post-translational 
modifications (dPTMs) of mitochondrial proteins [6]. Superoxide (𝑂2
•−), 
the origin of most O2 -derived free radicals, is overproduced and under 
scavenged during cardiac IR injury [1,7]. Under hypoxic or ischemic 
conditions, the mitochondrial electron transport chain (ETC) is initially 
in a highly reduced state [1], which results in electron leak so that O2 
is reduced to 𝑂2
•−. During reperfusion, 𝑂2
•−production, initiated during 
ischemia, is further exacerbated [1] because of diminished ADP levels, 
abundant O2, and poor ROS scavenging capability. Nitric oxide (NO•), 
a precursor of RNS, may also increase during IR [8,9]. When 𝑂2
•−is in 
excess it reacts with available NO• to generate peroxynitrite (ONOO−) 
[2,10], a highly reactive non-radical and a strong marker of RNS-
induced cell cytotoxicity. Indeed, a marked increase in ONOO− occurs 
during cardiac IR injury [4,5] and a reduction in injury is associated 
with decreased release of ONOO− [4,5]. 𝑂2
•− is a charged and diffusion 
limited molecule generated in mitochondria, whereas NO• is an 
uncharged, and diffusible molecule that easily traverses mitochondrial 
membranes. ONOO− has a half-life of about 3–5 ms in mitochondria 
and is a strong oxidant of mitochondrial proteins and lipids lying in 
close proximity [3]. Thus mitochondria can be both a site for ONOO− 
production and a target of ONOO− induced dPTMs [3]. For example, 
ONOO− mediates inactivation of mitochondrial manganese superoxide 
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dismutase (MnSOD) through nitration and oxidation of critical tyrosine 
residues [11,12]. However, the most vulnerable protein sites, the 
mechanisms by which ONOO− mediates damage to mitochondria, and 
the cardiac functional consequences are not well known. 
In general, ONOO− can directly oxidize molecules, decompose to 
NO2• and •OH, or react with CO2 to form C𝑂3
•−and NO2• [13]. These 
free radicals induce protein nitration, especially of exposed tyrosine 
(tyr) residues to form 3-nitrotyrosine (3-NT) [6]. Tyrosine nitration 
(tyr-N) is an established marker not only for RNS-induced stress 
resulting from ONOO− and its radical products, but also for ONOO− 
mediated cytotoxicity; once formed, 3-NT is relatively stable and the 
nitration can result in deleterious protein structural and functional 
changes [3,13]. Tyr-N may itself cause protein dysfunction and it may 
also prevent tyr phosphorylation by tyr kinases [14]. Although tyr-N is 
widely used as a biological assay indicative of ONOO− generation, it is 
acknowledged that ONOO− can also nitrate tryptophan and 
phenylalanine and that it also oxidizes other sites, e.g. FeS centers, 
protein thiols, and lipids [10]. Moreover, tyr-N may be induced by 
ONOO− independent oxidants like the gas NO2• formed by oxidation of 
N𝑂2
− (itself an oxidized product of NO•) in the presence of H2O2 by 
peroxidase, but high concentrations of this labile NO2• product are 
likely required to induce tyr-N [15]. 
Both in vivo and in vitro evidence indicates that proteins 
involved in oxidative phosphorylation and apoptosis can be nitrated in 
various diseases and disorders [16]. Nitration of proteins has been 
observed after IR injury [17–22], but the effect of IR on inducing 
irreversible dPTMs that alter the structure and function of key 
mitochondrial proteins has not been well examined. Liu et al. [17] 
indirectly identified 10 mitochondrial proteins including 4 subunits from 
the oxidative phosphorylation system, five enzymes in the matrix, and 
the voltage-dependent anion channel (VDAC) that were nitrated after 
IR injury using two-dimensional gel electrophoresis (2-DE) gel and 
mass spectrometry (MS) analysis. However, the identification of these 
tyr-N proteins using specific antibodies, and the determination of the 
specific sites of tyr-N by MS have not been undertaken; nor is it known 
if nitration of mitochondrial proteins during cardiac IR could be 
reduced by ROS/RNS scavenging or by inhibiting nitric oxide synthase 
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(NOS), and if identified nitrated mitochondrial proteins exhibit altered 
function. 
We proposed that some key mitochondrial proteins undergo tyr-
N during IR injury and that attenuating formation of ONOO− reduces 
tyr-N of these proteins and leads to improve cardiac function. Thus our 
first objective was to identify specific mitochondrial proteins that 
undergo enhanced tyr-N after cardiac IR injury. We identified VDAC as 
a tyr-N protein, and so pursued VDAC as a focus for additional studies. 
Although other proteins can be nitrated during IR injury, we focused 
on VDAC based on our initial results. We probed ONOO− induced tyr-N 
of recombinant (r) VDAC and its effect on changing rVDAC channel 
activity. In addition we tested if resveratrol (RES, trans-3, 4′, 5-
trihydroxystilbene), a putative 𝑂2
•− and ONOO− scavenger, and NG-
nitro-L-arginine methyl ester (L-NAME), an unspecific NOS inhibitor, 
could reduce the extent of tyr-N in mitochondrial proteins in 
association with reduced levels of 𝑂2
•− and ONOO− and improve 
functional recovery after IR injury in intact hearts. Our focus on the 
molecular aspect in this study provides amore mechanistic insight into 
how ROS/RNS impacts mitochondrial proteins and leads to the 
functional changes in myocardial function during IR. Such an in depth 
approach could provide for better strategies to mitigate IR injury. 
2. Methods 
2.1. Isolated heart preparation and protocols 
Hearts in situ cannot be used to detect 𝑂2
•− and ONOO−, so 
isolated hearts from guinea pigs were utilized to directly correlate 
changes in total cardiac oxidative stress and function in isolated 
mitochondria after IR injury. Our animal protocols conformed to the 
Guide for the Care and Use of Laboratory Animals (National Institutes 
of Health No. 85-23, Revised 1996) and were described previously 
[4,7,23,24] (see detailed descriptions in the Online Supplement 
Materials and Methods). After 30 min of global ischemia, or after 10, 
30, or 60 min reperfusion, hearts were removed and mitochondria 
were immediately isolated. In the treated groups either 100 µmol/L L-
NAME or 10 µmol/L RES was perfused for 10 min up to initiation of 
global ischemia so that the drug remained in the hearts during 
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ischemia. RES, 10 µmol/L, is cardioprotective in isolated rat hearts 
[25] and 100 µmol/L L-NAME blocks increased ONOO− production in 
17°C-perfused isolated hearts [24]. 
2.2. Detection of 𝑶𝟐
•−
 and ONOO− in isolated hearts 
The intracellular fluorescent probe dihydroethidium (DHE) 
(Molecular Probes) was used to assess 𝑂2
•− emission in isolated hearts 
as described previously (see Online Supplement Materials and 
Methods) [7,23,24,26]. After attaining stability, hearts were loaded 
with 10 µmol/L DHE for 20 min followed by washout of residual DHE 
for another 20 min. Dityrosine (DiTyr) was used to detect ONOO− 
formation indirectly as described previously (see Online Supplement 
Materials and Methods) [24]. ONOO− reacts with continuously perfused 
L-tyrosine (0.3 mmol/L) to form the fluorescent dimer DiTyr [9], a 
stable product at tissue pH [27]. DHE loaded/L-tyrosine perfused 
hearts were treated with/without RES/L-NAME before ischemia, 
followed by IR. 
2.3. Isolation of mitochondria 
Cardiac mitochondria were isolated at the end of each functional 
study using well-established methods in our laboratory [28–30] with 
minor modifications. All isolation procedures were carried out at 4 °C. 
Hearts were minced into very small pieces in a chilled isolation buffer 
containing 200 mmol/L mannitol, 50 mmol/L sucrose, 5 mmol/L 
KH2PO4, 5 mmol/L MOPS, 0.1% fatty acid free bovine serum albumin 
(BSA) and 1 mmol/L EGTA, at pH 7.15, then homogenized in 2.65 ml 
isolation buffer containing protease (5 U/ml, Sigma Cat: P-5495) for 
15 s with an ultrasonic homogenizer. After this, 15 ml of isolation 
buffer containing protease inhibitors (Roche, Complete protease 
inhibitor cocktail tablets) was added rapidly to the homogenate 
followed by another 15 s of homogenization. The slurried homogenates 
were centrifuged at 10,000 g for 5 min, and then the pellet was 
resuspended in isolation buffer containing protease inhibitors and 
centrifuged at 8000 g for another 10 min. After that, the pellet was 
resuspended in isolation buffer containing protease inhibitors and spun 
at 750 g for 10 min; then the supernatant was collected and 
centrifuged again at 8000 g. The resulting mitochondrial pellet was 
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resuspended in isolation buffer containing protease inhibitors and 
stored at −80 °C for later use. The amount of mitochondrial protein 
was assessed using Bio-Rad protein assay with BSA as the standard. 
2.4. Immunoprecipitation of mitochondrial proteins 
Immunoprecipitation (IP)was performed as described before 
[17,31] with minor changes. Mitochondria were pelleted and then 
lysed in RIPA buffer containing 50 mmol/L Tris-Cl pH 7.4, 150 mmol/L 
NaCl, 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS and 
protease inhibitors on ice for 30 min. The sample was pre-cleared with 
30 µl protein G Sepharose-4B beads (Invitrogen) for 1h at 4°C with 
constant end-over-end shaking and then centrifuged at 3000 g for 5 
min. The supernatant was collected, adjusted to 2 mg/ml protein 
concentration with RIPA buffer containing protease inhibitors, and 
subjected to IP with an anti-3-nitrotyrosine monoclonal antibody (anti-
3-NT, Millipore) or anti-VDAC antibody (Sigma) at 4 °C with constant 
end-over-end shaking overnight. The next day, after adding 30 µl 
protein G Sepharose-4B beads, the mixture was incubated for another 
2 h under the same conditions as above. The beads were collected and 
exhaustively washed (five times) with RIPA buffer. The final pellet was 
re-suspended in 50 µl sample buffer containing 50 mmol/L Tris-Cl, 
10% glycerol, 500 mmol/L β-mercaptoethanol, 2% SDS, 0.01% w/v 
bromophenol blue and protease inhibitors at pH 7.4 and boiled at 
95 °C for 5 min. The immunoprecipitated proteins were separated 
using SDS-PAGE. The gels were silver stained or subjected to Western 
blot analysis. 
2.5. Two-dimensional gel electrophoresis (2-DE) 
2-DE was performed with the IEF/Criterion gel system (Bio-
Rad). Mitochondrial pellets were lysed in lysis buffer containing 7.8 
mol/L urea, 2.2 mol/L thiourea, 4% CHAPS, and protease inhibitors on 
ice for 30 min, then desalted twice with Amicon 3 kDa (Millipore). After 
adding 65 mmol/L DTT and 1% Bio-Lyte ampholyte (pH3-10), about 
800 µg of protein from each sample was immediately loaded onto an 
11-cm nonlinear pH 3–10 IPG strip (Bio-Rad). The strips were 
rehydrated at 50 V for 12 h and then focused under the following 
conditions: voltage was first increased to 250 V over 20 min followed 
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by a linear increase to 8000 V over 70 min and then held at 8000 V 
until 26 kVh was attained. The focused IPG strips were then 
equilibrated for 15 min in 0.375 mol/L Tris-Cl, pH 8.8, 6 mol/L urea, 
20% glycerol, 2% SDS and 2% DTT followed by 15 min in 0.375 mol/L 
Tris-Cl, pH 8.8, 6 mol/L urea, 20% glycerol, 2% SDS and 2.5% 
iodoacetamide. The equilibrated strips were loaded on pre-cast gels 
(Criterion™10%, 11 cm; Bio-Rad) for the second dimension 
separation. The gels were run at 150 V for 70 min and then 
transferred onto polyvinylidene difluoride (PVDF) membranes for 
Western blot analysis with anti-VDAC and anti-3-NT antibodies. 
2.6. Western blot analysis 
Mitochondrial pellets were lysed in sample buffer and boiled at 
95 °C for 5 min. Mitochondrial samples (100 µg) or 
immunoprecipitates were resolved by SDS-PAGE and transferred onto 
PVDF membranes. Membranes were incubated with specific primary 
antibodies against 3-NT, VDAC (Cell Signaling), and ANT (adenine 
nucleotide translocator, Santa Cruz). Washed membranes were 
incubated with the appropriate secondary antibody conjugated to 
horseradish peroxidase, then immersed in an enhanced 
chemiluminescence detection solution (GE Healthcare) and exposed to 
X-Ray film for autoradiography. For monitoring loaded protein 
amounts, VDAC or ANT protein was used as loading controls because 
VDAC and/or ANT are mitochondrial membrane proteins and their 
detection confirms mitochondrial isolation. Blots were stripped with 
buffer (62.5 mmol/L Tris-Cl, 2% SDS, and 100 mmol/L β-
mercaptoethanol at pH 6.8), and then probed with specific antibodies 
against VDAC or ANT. 
2.7. In-gel tryptic digestion of protein bands 
Protein bands from silver-stained gels were excised and cut into 
small pieces and then subjected to in-gel digestion by trypsin as 
described by Newman et al. [32]. In brief, after destaining silver ions 
with a 1:1 solution of 100 mmol/L Na2S2O3 and 30 mmol/L K3Fe9(CN)6, 
the gel pieces were dehydrated with 50% acetonitrile and then 25 
mmol/L (NH4)HCO3/50% acetonitrile (pH 8.0). The dehydrated gel 
pieces were dried and then digested with 40 ng trypsin in 100 µl of 25 
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mmol/L (NH4)HCO3 (pH 8.0) overnight at 37 °C. Tryptic fragments 
were extracted from gel slices with acetonitrile/trifluoroacetic acid 
(TFA)/water (70:0.1:29.9 v/v/v). Extracted samples were dried and 
prepared either for LC–MS/MS or MALDI-TOF MS analysis. 
2.8. Protein identification by LC–MS/MS mass 
spectrometry 
Extracted tryptic fragments were subjected to LC–MS/MS 
analysis using a LTQ (Thermo-Fisher) MS coupled to a Surveyor HPLC 
system equipped with a Micro AS auto sampler. Separation of tryptic 
peptides was achieved online before MS/MS analysis on an Aquasil, 
C18 PicoFrit capillary column (75 mm × 100 mm; New Objective) with 
the following conditions: mobile phase A, 0.1% formic acid containing 
5% acetonitrile; and mobile phase B, 0.1% formic acid in 95% 
acetonitrile, respectively. A 180 min linear gradient was applied. The 
ions eluted from the column were electro-sprayed at a voltage of 1.75 
kV. MS/MS spectra data were analyzed using the SEQUEST search 
engine and analysis carried out via the Visualize software program 
[33]. The SEQUEST search parameters were set with no fixed 
modification, one missed trypsin cleavage site, a peptide tolerance of 
1.2 Da, and a MS/MS tolerance of 0.8 Da, and then searched against 
the rodent subset of the Uniprot database. All proteins identified had 
to meet a False Discovery Rate (FDR) of 1.5% or less. 
2.9. Protein identification by MALDI-TOF mass 
spectrometry 
MALDI-TOF MS was also performed as described by Newman et 
al. [32]. Briefly, the dried extracted samples were resuspended in 20 
µl 0.1% TFA and subjected to purification using Micro-C18 Zip-Tips 
(Millipore). The purified samples were eluted in 1–2 µl volume of α-
cyano-4-hydroxycinnamic acid in 60% acetonitrile/0.1% TFA and then 
directly loaded on the sample plate for analysis using a Voyager DE 
PRO MALDI-TOF mass spectrometer in positive ion, reflector, delayed-
extraction mode (Applied Biosystems). Peptide masses were analyzed 
using the Protein Prospector software 
(http://prospector.ucsf.edu/prospector/mshome.html). 
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2.10. Nitration of recombinant VDAC induced by 
exogenous ONOO− in vitro 
Because VDAC was identified as a key tyr-N protein after cardiac 
IR injury, we further explored for specific VDAC tyr-N residues and 
determined if tyr-N of VDAC affects its structure and function. To do so 
we exposed recombinant VDAC (rVDAC) to different concentrations of 
exogenous ONOO− to induce concentration-dependent nitration of 
rVDAC in vitro. Rat VDAC-1 full-length cDNA (GenBank: BC072484, 
purchased from Open Biosystems) was cloned into pET-21a vector 
(Novagen) and expressed in BL21 cells. rVDAC proteins were extracted 
with BugBuster Master Mix (Novagen) and purified with Ni-NTA 
His·Bind Resins (Novagen). Purified rVDAC was refolded at 4 °C by 
dropwise dilution of one volume protein with 10 volumes refolding 
buffer containing 20 mmol/L Tris-Cl, 100 mmol/L NaCl, 1% 
lauryldimethylamineoxide (LDAO), and 1 mmol/L DTT at pH 7.4 
[34,35]. It has been reported that using the detergent LDAO resulted 
in a 90% refolding of rVDAC compared to 75% and 30% for the 
detergents DDM or C8E4, respectively [35]. After refolding, the 
refolded rVDAC protein was dialyzed against refolding buffer, without 
DTT, at 4 °C to remove the DTT. The reconstituted rVDAC was used 
for in vitro nitration by ONOO−. ONOO− (Calbiochem) concentration 
was determined by absorbance at 302 nm with an extinction 
coefficient of 1670 M−1 cm−1 in 100 mmol/L of NaOH prior to use [36]. 
For exposure of rVDAC to ONOO−, 500 µg of rVDAC at 3 mg/ml was 
incubated with 0–400 µmol/L ONOO− at 23 °C for 30 min. The ONOO−-
treated rVDAC was subjected to SDS-PAGE or 2-DE, followed by 
Western blot with antibodies against 3-NT and VDAC, or gels were 
stained with silver staining and VDAC bands were cut for MALDI-TOF 
MS. 
2.11. Reconstitution of rVDAC into planar lipid bilayers 
for channel activity 
Channel activity of rVDAC was monitored by incorporating 
rVDAC into planar lipid bilayers (PLB), as previously described [37]. 
Briefly, phospholipids were prepared by mixing 
phosphatidylethanolamine, phosphatidylserine and phosphatidylcholine 
(Avanti Polar Lipids, Alabaster, AL) in a ratio of 5:4:1 (v/v); the 
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phospholipids were dried under N2 and re-suspended in n-decane to a 
final concentration of 25 mg/ml. The cis/trans chambers contained 
identical solutions of 10 mmol/L HEPES, 500 mmol/L NaCl and 1 
mmol/L CaCl2 at pH 7.4. The cis chamber was held at virtual ground 
and the trans chamber was held at the command voltages. rVDAC 
protein was added into the cis chamber. After channel incorporation 
into the bilayer, ONOO− was added to the cis chamber and diluted 
proportionally to achieve the desired concentration of 50 µmol/L. 
Currents were sampled at 5 kHz and low pass filtered at 1 kHz using a 
voltage clamp amplifier (Axopatch 200B, Molecular Devices) connected 
to a digitizer (DigiData 1440, Molecular Devices), and recorded in 1 
min segments. The pClamp software (version 10, Molecular Devices) 
was used for data acquisition and analysis. Additional analyses were 
conducted using Origin 7.5 (OriginLab). 
2.12. Statistical analysis 
All results are expressed as means ± SEM and were analyzed by 
one-way ANOVA followed by a post-hoc analysis (Student–Newman–
Keuls' test) to determined statistically significant differences of means 
among groups. A value of p < 0.05 was considered significant (two-
tailed). 
3. Results 
3.1. 𝑶𝟐
•− and ONOO− production increase in isolated 
hearts during IR injury 
DHE fluorescence (𝑂2
•−emission) increased during ischemia; on 
reperfusion, it declined abruptly, but remained higher than baseline 
values (Fig. 1A, IR10), consistent with our previous findings [7,23,26]. 
Similarly, DiTyr fluorescence (ONOO−) increased and remained 
elevated during ischemia; on reperfusion it decreased to baseline 
levels (Fig. 1B, IR10). Time control (TC) groups showed no significant 
changes in DHE (𝑂2
•−) and DiTry (ONOO−) fluorescence during the 
duration of the perfusion protocol (Fig. 1A and B, TC). 
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Fig. 1 Time course of changes in superoxide (𝑂2
•−) and peroxynitrite (ONOO−) 
levels during IR. A: The fluorescence probe DHE, via its stable (ethidium) or unstable 
and labile 2-hydoxyethidium (2-OH-E+) product was used to assess intracellular 
𝑂2
•− emission online in isolated hearts at the LV free wall. B: Dityrosine (DiTyr) 
fluorescence formed from L-tyrosine in the presence of ONOO− was used to monitor 
ONOO− online similar to that described for the DHE fluorescence probe. TC: Time 
control; IR10: 30 min ischemia and 10 min reperfusion; N = 4–5 hearts/group/probe; 
Values are mean ± SEM. *: p < 0.05 vs. TC. See Table 1 for functional data. 
These changes in 𝑂2
•− and ONOO− generation also correlated 
with the changes of function in isolated hearts. Systolic–diastolic left 
ventricular pressure (dLVP), indices of contractility and relaxation 
(dLVP/dtmax and dLVP/dtmin) respectively decreased, while diastolic LVP 
increased during ischemia (Table 1, IR10, IR60); during reperfusion, 
dLVP/dtmax, dLVP/dtmin and dLVP recovered to almost half the pre-
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ischemia values while diastolic LVP remained significantly higher than 
the pre-ischemia level (Table 1, IR10, IR60). Cardiac function was 
unchanged over time in the TC groups (see Online Supplement Table 
S3). Heart rate was unchanged on reperfusion compared to pre-
ischemia in all groups (Table 1). 
3.2. Mitochondrial protein tyr-N increases after cardiac 
IR injury 
The isolated heart experiments strongly implicated the potential 
for cardiac protein tyr-N, as a marker of ONOO−-induced dPTMs. 
Because mitochondrial dysfunction plays a key role in IR injury, we 
assessed concurrently the extent of mitochondrial protein tyr-N. 
Mitochondria isolated from TC, I30, IR10, IR30 and IR60 groups were 
subjected to Western blotting with anti-3-NT antibody. Several 
immunoreactive bands were detected in all groups (Fig. 2A). 
Compared to TC, IR caused an increase in anti-3-NT band signal 
intensity at 35 kDa and 15 kDa. To exclude the possibility that 
stronger anti-3-NT signals were derived from large amounts of protein 
loaded, we chose ANT (~35 kDa) protein as the loading control, which 
was similar in all groups (Fig. 2A). Comparison of the ratio of densities 
of anti-3-NT bands to anti-ANT bands DHE fluorescence (afu) among 
all groups (Fig. 2B) clearly confirmed that enhanced anti-3-NT 
immunoreaction occurred in the IR groups. 
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Table 1 Cardiac function in IR10, 60, resveratrol and L-NAME treated IR10 groups 
during baseline, ischemia 30 min and reperfusion 10 and 60 min. 
 
 
IR10: 30 min of ischemia and 10 min of reperfusion; IR60 only in non-treated group; 
sys–dia LVP, systolic–diastolic left ventricular pressure; dLVP/dtmax, index of 
contractility; dLVP/dtmin: index of relaxation; N = 8–10 hearts/group. Values are 
mean ± SEM. *p < 0.05: IR10 + RES, IR10 + L-NAME vs. IR10, 60. 
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Fig. 2 Assessment of tyr-N of mitochondrial proteins isolated from hearts and 
identity of tyr-N mitochondrial proteins. A: Assessment of tyr-N of cardiac 
mitochondrial proteins from TC and IR groups hearts by Western blot with anti-3-NT 
antibody. Amounts of loaded mitochondrial proteins were monitored with anti-ANT 
antibody. B: Densitometric analysis of Western blot of tyr-N of mitochondrial proteins. 
The densities of anti-3-NT bands at about 35 kDa and 15 kDa, and ANT bands were 
measured using ImageJ system, after which % density of each anti-3-NT bands was 
normalized to % density of their corresponding ANT bands. A is a representative blot 
and B is the mean ± SEM of four experiments. *: p < 0.05 vs. TC group. TC: time 
control; I: Ischemia; R: Reperfusion. MW: molecular weight. C: Mitochondrial proteins 
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isolated from IR groups were subjected to IP with anti-3-NT antibody followed by 
Western blots with indicated antibodies. Lanes 1 and 3: total mitochondrial protein 
lysates (input); lanes 2 and 4: IP with anti-3-NT antibody. MW: molecular weight; WB: 
Western blot. D: VDAC from mitochondrial protein of TC and IR10 groups was first 
individually immunoprecipitated with anti-VDAC antibody. The immunoprecipitates 
were subjected to Western blotting with anti-3-NT antibody and then the membrane 
was stripped and reblotted with anti-VDAC antibody. E: Densities of anti-3-NT bands 
and VDAC bands in TC and IR10 groups were measured using ImageJ system, after 
which % density of each anti-3-NT bands was normalized to % density of their 
corresponding VDAC bands. WB: Western blot. D is a representative blot and E is the 
mean ± SEM of three experiments. *: p < 0.05 IR10 vs. TC. 
 
3.3. Identity of tyr-N mitochondrial proteins with 
specific antibodies and mass spectrometry 
To identify the enhanced tyr-N proteins implicated by the 
Western blot above (Fig. 2A), we subjected the total mitochondrial 
protein extracts from IR groups to IP with an anti-3-NT antibody. After 
IP, the immunoprecipitates were subjected to SDS-PAGE to remove 
the detergent and collect sample for LC–MS/MS assay. After the 
immunoprecipitates entered the separating gel part of the SDS-PAGE 
gel from loading wells, the gel was run for 5 min and then silver 
stained. The silver stained protein areas on the gel that include all 
sizes of proteins were collected and cut into two parts for LC–MS/MS 
(Fig. S1 lane 1, Online Supplement). Initially, 13 mitochondrial 
proteins were obtained from immunoprecipitates of the anti-3-NT 
(Table S1, Online Supplement). Four of these were polypeptides from 
the ETC and five were components of the TCA cycle. Notably, two 
proteins, VDAC and ANT, with molecular weights of about 35 kDa, 
which are similar to the above Western blot 35 kDa tyr-N protein band 
size (Fig. 2A), were also obtained. This indicated that these two 
proteins might be candidates of tyr-N mitochondrial proteins. 
We used protein specific antibodies to further identity tyr-N 
proteins displayed on the Western blots. Based on molecular weights 
of the candidate proteins listed in Online Supplement Table S1 and on 
Western blot analyses (Fig. 2A), we focused on identifying whether 
ANT and/or VDAC was the 35 kDa tyr-N protein. IP assays of 
mitochondrial protein extracts of IR groups were carried out with anti-
3-NT antibody followed by Western blotting with antibodies against 
VDAC and ANT. Immunoreactive signals were detected when the VDAC 
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antibody was used to probe anti-3-NT immunoprecipitates (Fig. 2C, 
Lane 4). This corresponded to a similar size 35 kDa band in the total 
mitochondrial protein lysate probed with anti-VDAC antibody (Fig. 2C, 
Lane 3, input) or probed with anti-3-NT antibody (Fig. 2A). In 
contrast, when ANT antibody (Fig. 2C, Lane 2) was used no 
immunoreactive signal was detected from the anti-3-NT 
immunoprecipitates. These data strongly implicated VDAC as the 35 
kDa protein exhibiting enhanced tyr-N after IR injury. A 15 kDa 
mitochondrial protein also displayed enhanced tyr-N in IR groups on 
Western blot and we also found 3 proteins with molecular weights 
about 15 kDa (see Online Supplement Table S1); identity of these tyr-
N proteins is as yet incomplete; our intent here was to focus only on 
VDAC. 
Next we utilized an approach reported by Tran et al. [38] to 
compare the relative ratio of nitrated VDAC to total VDAC between the 
TC and IR groups. Based on Fig. 2A results, at the 35 kDa protein, the 
IR10 group displayed a similar tyr-N level as the IR60 group, but 
higher than the IR30 group. Therefore, we chose the IR10 group to 
compare with the TC in this and all other experiments. Mitochondria 
were isolated as described in Method (see Method 2.3) from TC and 
IR10 hearts. VDAC was first immunoprecipitated with anti-VDAC 
antibody (Sigma) from mitochondrial protein lysate of TC and IR10 
groups individually. The immunoprecipitates were subjected to 
Western blotting with anti-3-NT antibody, and then the membranes 
were stripped and reblotted with anti-VDAC antibody (Cell Signaling). 
The resulting Western blots showed that similar amounts of VDAC 
protein were immunoprecipitated from the TC and IR10 groups (Fig. 
2D, bottom panel), whereas immunoprecipitated tyr-N VDAC increased 
in the IR10 group compared to the TC group (Fig. 2D, upper panel). 
Comparison of the relative ratio of the tyr-N VDAC bands to the total 
VDAC bands clearly confirmed that IR increased VDAC nitration 
significantly by approximately 4 fold (Fig. 2E). This result (Fig. 2D, E) 
was similar to the result of Western blotting with anti-3-NT shown in 
Fig. 2A and B, which displayed a 35 kDa protein (identified as VDAC) 
with a higher tyr-N level in the IR than in the TC group. 
To further confirm tyr-N of VADC, mitochondrial proteins from 
TC and IR10 groups were subjected to 2-DE individually, followed by 
Western blots with anti-3-NT antibody. After blotting with anti-3-NT 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochimica et Biophysica Acta: Bioenergetics, Vol. 1817, No. 11 (November 2012): pg. 2049-2059. DOI. This article is © 
Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant 
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from 
Elsevier. 
18 
 
antibody, the membranes were stripped and then reblotted with anti-
VDAC antibody. The results showed that VDAC spots (solid tilted 
arrows) displayed strong immunoreactivity to anti-3-NT antibody in 
the IR10 group (Fig. S2B, D, Online Supplement), whereas in the TC 
group, the VDAC spot (dotted tilted arrows) showed only a slight 
immunoreactive signal with anti-3-NT antibody (Fig. S2A, C, Online 
Supplement). Why two VDAC spots showed immunoreactivity to anti-
3-NT antibody (solid tilted arrows, Fig. S2, Online Supplement) in the 
IR10 group is unclear at this time. 
3.4. ONOO− induces tyr-N of rVDAC in vitro 
The aim of these experiments was to identify specific tyr-N 
residues and further confirm tyr-N of VDAC. Purified rVDAC was 
exposed to ONOO− (0–400 µmol/L) and the ONOO−-treated rVDAC 
protein was subjected to Western blotting with anti-3-NT antibody. Our 
approach showed that rVDAC can be nitrated by as low as 10 µmol/L 
of ONOO− (Fig. 3A); moreover, signal intensity of tyr-N of rVDAC 
increased as [ONOO−] increased. Some tyr-N of rVDAC protein 
exhibited slow mobility on the SDS-PAGE gel. In addition to the 35 
kDa bands (rVDAC monomer), additional bands with molecular weights 
of approximately 65 kDa, 100 kDa, and higher appeared. This 
indicated formation of higher molecular mass species (Fig. 3A) and 
suggested that tyr-N induced a structural alteration of rVDAC that led 
to protein oligomerization. 
In addition, we examined the characteristics of rVDAC incubated 
with ONOO− by 2-DE. In this experiment, we chose one concentration 
of ONOO−, i.e. 200 µmol/L, to treat rVDAC. After treatment rVDAC 
appeared as 4 adjacent spots (Fig. S3B and D, Online Supplement); 
three of these spots revealed equal signal intensities to anti-3-NT 
antibody and to anti-VDAC antibody, whereas most of the control 
(non-nitrated) rVDAC were accumulated at two adjacent spots and 
showed no immunoreactivity to anti-3-NT antibody (Fig. S3A and C, 
Online Supplement). 
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Fig. 3. Tyr-N of recombinant (r) VDAC induced by ONOO−in vitro. A: rVDAC was 
incubated with 0–400 μmol/L ONOO− and subjected to Western blot with anti-3-NT 
antibody. rVDAC loading was monitored with anti-VDAC antibody. B: Mass 
spectrometric characterization of the peptide fragment 62YRWTEYGLTFTEK74 
determined by MALDI-TOF MS. Peaks labeled at m/z 1693 correspond to the peptide 
containing an unmodified tyr residue and peaks labeled at m/z 1738 correspond to the 
same peptide as m/z 1693, but with a tyr-N residue, i.e. one that displays a + 45 
mass unit shift. MW: molecular weight 
To identify possible tyr-N residues in the rVDAC, we excised 
ONOO−-untreated (0 µmol/L) and 100, 200, 400 µmol/L ONOO−-
treated rVDAC bands on silver stained SDS-PAGE gels, and then 
subjected them to MALDI-TOF MS. The sensitivity of the MALDI-TOF 
MS assay is lower than that of the Western blots, because in the MS 
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analysis only 1–2 µl of trypsin-digested sample was loaded on the 
sample plate, and the laser beam hits peptide fragments partially and 
randomly. Therefore, for this experiment 100, 200, 400 µmol/L of 
ONOO− was used to treat rVDAC. Nine of 11 total tyr residues (Y) of 
rVDAC were detected by MALDI-TOF MS, specifically, 22Y, 62Y, 67Y, 146Y, 
153Y, 173Y, 195Y, 225Y and 247Y (Online Supplement Table S2). Among the 
identified Y-containing peptide fragments, one fragment, 
62YRWTEYGLTFTEK74, displayed a +45 mass units' shift from m/z 1693 
to 1738 in ONOO−-treated rVDAC (Fig. 3B), consistent with a single 
NO2 group added to either 62Y or 67Y. In ONOO−-untreated (control) 
rVDAC, the intensity of spectrum m/z 1693 was highest among all four 
groups, while the spectrumm/z 1738 was absent. In ONOO−-treated 
rVDAC, the intensity of spectra m/z 1693 decreased gradually with 
increasing [ONOO−], while spectra m/z 1738 appeared among the 
three ONOO−-treated rVDAC groups (Fig. 3B). The site(s) identified in 
ONOO−-treated rVDAC may or may not be the same as in native VDAC 
after IR injury. 
3.5. Resveratrol or L-NAME treatments reduce 
mitochondrial protein tyr-N 
We next examined if the enhanced protein tyr-N during IR is 
attributable to the increases in ONOO− formation resulting from 
combined generation of NO• and 𝑂2
•−. Hearts were treated with L-
NAME or RES before 30 min ischemia, followed by IR, and tyr-N of 
mitochondrial proteins was again evaluated as described above (see 
Results 3.2) by Western blot with anti-3-NT antibody. Both RES and L-
NAME reduced tyr-N of 35 kDa (identified as VDAC) and 15 kDa 
mitochondrial proteins compared to the untreated group (Fig. 4A, B). 
These data indicated that ONOO− produced during IR injury induced 
mitochondrial protein nitration, in particular tyr-N of VDAC. 
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Fig. 4 Inhibitory effects of L-NAME and resveratrol (RES) on mitochondrial protein 
tyr-N. A: Isolated hearts were treated without or with L-NAME (100 μmol/L) or RES 
(10 μmol/L) for 10 min before the onset of ischemia. After reperfusion, mitochondria 
were isolated and tyr-N of mitochondrial protein was evaluated by Western blot with 
an anti-3-NT antibody. The amount of mitochondrial protein loaded was assessed by 
reprobing the membrane with anti-ANT (A, lower panel). B: Densities of anti-3-NT 
bands at about 35 kDa, 15 kDa and ANT bands were measured using the ImageJ 
system, and then density of each anti-3-NT bands was normalized to their 
corresponding ANT band. A is a representative blot and B is means ± SEM of all 
experiments performed in triplicates. #: p < 0.05, compared to IR10. 
To correlate the preventive effects of L-NAME and RES on 
mitochondrial protein tyr-N with cardioprotection during IR injury, we 
monitored ONOO− and 𝑂2
•− production online in isolated hearts. L-NAME 
attenuated DiTyr fluorescence (ONOO−) levels during ischemia (Fig. 
5B). We showed previously that L-NAME reduced cold-induced ONOO− 
production, but that it did not alter 𝑂2
•− emission [24]. Because RES 
interfered with the DiTyr fluorescence signal, we could only monitor 
the 𝑂2
•− emission with DHE fluorescence. RES attenuated DHE 
fluorescence (𝑂2
•− emission) induced during ischemia and completely 
blocked it during reperfusion (Fig. 5A). Reduction of DiTyr/DHE 
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fluorescence by L-NAME and RES was associated with a significant 
improvement in cardiac function during reperfusion (Table 1). 
Collectively, reducing ONOO−/𝑂2
•− production during IR decreased 
protein tyr-N, and at the same time improved recovery of function on 
reperfusion. 
 
Fig. 5 Effects of L-NAME and resveratrol on 𝑂2•−  and ONOO− production in isolated 
hearts. Levels of 𝑂2
•−  and ONOO− were measured online with DHE (A) and L-tyrosine 
(B), respectively, as described in section 2. DHE/DiTyr fluorescence intensities in 
arbitrary fluorescence units (afu) were normalized to zero at baseline. *: p < 0.05, 
compared to IR10 + RES/L-NAME. TC: time control; IR10: Ischemia 30 min, 
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reperfusion 10 min; RES: resveratrol; L-NAME: NG-nitro-L-arginine methyl ester; MW: 
molecular weight. 
 
3.6. Resveratrol reduces rVDAC tyr-N in vitro 
To verify that L-NAME and RES attenuated VDAC tyr-N during 
IR, rVDAC was incubated with ONOO− (0–100 µmol/L), with or without 
RES or L-NAME; rVDAC tyr-N was evaluated again by Western blot 
using anti-3-NT antibody. Incubation with ONOO− resulted in tyr-N of 
rVDAC (Fig. 6A). RES, 100 µmol/L, abolished tyr-N of rVDAC, while L-
NAME (100 µmol/L) had no effect. The inhibitory effect of RES on 
ONOO− induced rVDAC tyr-N was concentration-dependent, such that 
greater than 10 µmol/L RES inhibited rVDAC tyr-N induced by 20 
µmol/L of ONOO− (Fig. 6B). This suggests that L-NAME inhibits only 
generation of NO• in the presence of NOS, whereas RES scavenges 
both 𝑂2
•−  and ONOO−. 
 
Fig. 6 Inhibition of recombinant (rVDAC) tyr-N by L-NAME and resveratrol (RES) in 
vitro. A: rVDAC was incubated with ONOO− (0–100 μmol/L), with or without L-NAME 
(100 μmol/L) or RES (100 μmol/L), and subjected to Western blot with an anti-3-NT 
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antibody. rVDAC loading was monitored with VDAC antibody. B: Western blot analysis 
of rVDAC incubated with 20 μmol/L of ONOO− without or with 5–100 μmol/L RES with 
anti-3-NT antibody. Values are mean ± SEM of three experiments. *: p < 0.05 vs. 
non-treated VDAC. 
3.7. ONOO− enhances rVDAC conductance 
We next investigated if ONOO− altered rVDAC activity by 
recording single channel conductance after reconstituting rVDAC into 
PLB. We assumed that ONOO− is the major species inducing tyr-N of 
rVDAC. rVDAC exhibited a characteristic voltage-dependent 
conductance (Fig. 7A), which is similar to native VDAC (Fig. S4, right 
panel, Online Supplement) [37]. The effect of ONOO− on rVDAC was 
monitored at a membrane potential of −10 mV. Under control 
conditions, primary rVDAC chord conductance was approximately 1.8 
nS as depicted by the unitary current amplitude of 18 pA (Fig. 7B). 
When 50 µmol/L ONOO− was added, channel activity was enhanced 
with multiple higher conductance states, as evidenced by current 
amplitudes of −25 pA and −30 pA (Fig. 7B). These experiments 
demonstrate that 50 µmol/L ONOO− directly enhanced rVDAC 
conductance. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochimica et Biophysica Acta: Bioenergetics, Vol. 1817, No. 11 (November 2012): pg. 2049-2059. DOI. This article is © 
Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant 
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from 
Elsevier. 
25 
 
 
 
Fig. 7 Effects of ONOO− on recombinant (r) VDAC channel activity. A: 
Characteristic voltage-dependence of rVDAC in response to a ramp 
voltage protocol from − 80 to + 80 mV under control conditions. B: 
Effects of adding ONOO− on rVDAC activity. Current traces show in 
control and after adding 50 μmol/L ONOO− obtained at a membrane 
potential of − 10 mV. In control, primary conductance was 1.8 nS. 
Application of ONOO− triggered enhanced opening of VDAC as 
evidenced by the multiple conductance states. Corresponding all-
points amplitude histograms are also shown. 
4. Discussion 
The functional and biological consequences of tyr-N depend on 
which proteins are nitrated as well as on the extent and sites of 
nitration in a given protein [39]. Identifying tyr-N of mitochondrial 
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proteins should help to define the potential pathogenic role of this 
dPTM in disease states and to provide guidance on how and where to 
target therapies against these dPTMs. Although there are prior reports 
[8,17] that IR injury induces tyr-N of mitochondrial proteins, only a 
few proteins so far have been identified, and there has been no direct 
evidence for VDAC nitration or for specifically nitrated tyr residues. 
Here we used proteomic analyses and IP assays to search for specific 
proteins that undergo enhanced tyr-N during IR in isolated perfused 
hearts. We found that VDAC, a key and abundant outer mitochondrial 
membrane (OMM) protein was targeted for tyr-N during IR. Consistent 
with our isolated heart results, the in vitro experiments confirmed that 
rVDAC can be nitrated by ONOO− at either the 62Y or 67Y site. In 
addition, our results indicate that rVDAC tyr-N may trigger 
oligomerization of rVDAC and that ONOO− enhances rVDAC channel 
conductance. Thus, nitration of VDAC likely induces alterations in both 
its structure and function. 
To further explore mechanisms of tyr-N induction, RES or L-
NAME was perfused into isolated hearts before ischemia as well as 
applied to rVDAC protein. In isolated hearts, both RES and L-NAME 
decreased VDAC tyr-N, inhibited formation of ONOO−, and improved 
cardiac function after IR. In vitro, RES, but not L-NAME, directly 
prevented tyr-N of rVDAC induced by ONOO−. Lastly, in vitro tyr-N of 
rVDAC confirmed our ex vivo results that RES indeed can scavenge 
ONOO− to reduce tyr-N. Overall, our study suggests that VDAC tyr-N 
occurs during IR injury and that scavenging O∙−2/ONOO− and 
attenuating NO• generation reduces tyr-N of VDAC during IR. 
4.1. Sites of VDAC tyr-N and functional change 
Previous studies suggested that VDAC tyr-N can occur in mouse 
hearts during IR injury [17], in old-aged rat hearts [31], and in rat 
hippocampal tissue after acute smoke inhalation [40]. In those 
studies, VDAC was suggested as a nitrated protein based on MS 
analysis for anti-3-NT positive protein spots on 2-DE gels or anti-3-NT 
IP protein mixtures. However, there was no direct evidence of VDAC 
tyr-N or of attenuated VDAC tyr-N by inhibitors/scavengers of ONOO−. 
Moreover, the impact of tyr-N on rVDAC channel conductance was 
unknown. Based on our multifaceted approaches involving MS 
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analysis, IP, and electrophysiology, we provide firm evidence that 
VDAC tyr-N occurs during cardiac IR injury. Moreover, tyr-N appears 
to oligomerize rVDAC and ONOO− increases the rVDAC channel 
conductance state. We also newly report that partial prevention of 
VDAC tyr-N is associated with improved cardiac function. 
Protein tyr-N is a selective process, in so far as not all proteins 
can be nitrated. The potential for a protein to become nitrated is 
affected by the cellular and subcellular localization of a given protein 
[41]. Most nitrating agents are short-lived [42,43], so proteins to be 
nitrated must lie in close proximity to the site of ONOO− formation. 
Because NO• is a diffusible molecule and 𝑂2
•−  is diffusion limited and 
generated primarily in mitochondria, ONOO− is most likely formed in 
mitochondria. As the most abundant protein in the OMM, VDAC is 
likely highly exposed to ONOO−. Thus it is probable that VDAC is an 
easy target during IR injury for attack by ONOO− with subsequent tyr-
N. 
We examined for a direct functional impact of ONOO− on VDAC 
by treating rVDAC incorporated into PLB with ONOO− and found that 
50 µmol/L ONOO− enhanced rVDAC channel activity, as shown as 
multiple higher conductance states. This may allow increased transport 
of metabolites across a “leakier” OMM. It is possible that the higher 
conductance states permit release of cytochrome c across the OMM via 
VDAC, independent of mitochondrial permeability transition pore 
(mPTP). How ONOO− enhances VDAC channel conductance is unclear. 
Despite our finding that ONOO− induced higher rVDAC channel 
conductance states, it is not established if higher or lower VDAC 
channel conductance states contribute to impaired mitochondrial 
function during cardiac IR injury. We reported recently a 
concentration-dependent, biphasic inhibitory effect of exogenous NO• 
on cardiac VDAC [37]. Peak inhibition occurred at a physiologically 
relevant level of NO•, and this correlated with a delay in mitochondrial 
permeability transition pore (mPTP) opening. Consequently, a NO•-
induced delay in mPTP opening, in tandem with an induced low 
conducting state of VDAC, could potentially contribute to myocardial 
protection. This would then support our hypothesis that the ONOO−-
induced high conductance state of VDAC is detrimental to cardiac 
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function, whereas the putatively protective NO•-induced low 
conductance state is beneficial. 
It is likely that ONOO−-induced VDAC tyr-N leads to structural 
alterations because tyr-N renders the neutral tyr residue a charged 
residue; this could alter the tertiary structure of VDAC. Indeed, we 
found that nitration of rVDAC caused it to oligomerize into dimers or 
trimers (Figs. 3, ,6).6). Keinan [44] reported that oligomerization of 
VDAC1 was associated with cytochrome c release and apoptosis 
induced by various stimuli in many cell types. Although we did not 
show directly that VDAC tyr-N is associated with cell death, our recent 
data indicate that IR-induced release of cytochrome c [45] occurs at 
the same time as tyr-N of mitochondrial proteins (and in particular, 
VDAC based on our current study). Thus our study suggests that VDAC 
tyr-N may be associated with mitochondrial-mediated cell death. 
A rVDAC residue that is a target of nitration was narrowed to 
either 62Y or 67Y. The specific tyr residues capable of tyr-N are 
determined by both the protein's structure and the local environment 
around the tyr (Y) residues [41]. Most tyr-N residues have been found 
in loop structures in the vicinity of turn-inducing amino acids such as 
proline or glycine [41,46]. The proximity of negatively charge 
residues, such as glutamic or aspartic acids, also benefits nitration of 
tyr [41,46]. In our tyr-N containing peptide sequence, 67Y is adjacent 
to the turn-inducing residue glycine and the negatively charge residue 
glutamic acid, which conforms well to common features of structural 
determinants of protein tyr-N. In addition, based on elucidation of the 
three-dimensional structure of VDAC, 67Y is located in the loop region 
between the β3 and β4 strands [47]. Consequently, 67Y is likely the 
nitrated residue in the rVDAC, but for now nitration of 62Y cannot be 
excluded. 
4.2. Reduced mitochondrial protein tyr-N occurs with 
improved recovery after IR injury 
There is now ample evidence that RNS/ROS-induced protein tyr-
N is a critical factor underlying cardiac IR injury [19,48]. Inhibiting 
NOS activity reduced both the level of protein nitration and the extent 
of IR injury [5]. Our present and prior studies, in which we measured 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochimica et Biophysica Acta: Bioenergetics, Vol. 1817, No. 11 (November 2012): pg. 2049-2059. DOI. This article is © 
Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant 
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from 
Elsevier. 
29 
 
ONOO−, i.e. DiTyr fluorescence, in the left ventricle [24] and in 
coronary effluent [4], demonstrate that inhibiting NOS with L-NAME 
can attenuate the increase in ONOO− induced during IR injury (Fig. 
5B). To support these prior heart studies, we report here that L-NAME 
also decreased IR-induced mitochondrial proteins tyr-N (Fig. 4A), while 
improving functional recovery during reperfusion (Table 1). The rapid 
fall in DiTyr fluorescence signal for ONOO− on reperfusion in isolated 
hearts is due to washout of free DiTyr in the effluent. Overall, reducing 
VDAC tyr-N by attenuating NO• generation, and thus ONOO−, by L-
NAME may play a supportive role in ameliorating IR injury. 
To further evaluate the effects of mitochondrial protein tyr-N in 
IR injury, we tested effects of an inhibitor/scavenger of RNS/ROS, i.e. 
RES, on reducing protein tyr-N and improving functional recovery. RES 
is purported to have anti-inflammatory, anti-aging, anti-neoplastic, 
and cardioprotective properties [49]. RES may react directly with 
ONOO− to act as a functional ONOO− scavenger in vitro and thereby to 
prevent or mitigate ONOO−-induced tyr-N [50]. Although RES reduced 
hypoxia-induced 𝑂2
•−  emission in cardiomyocytes has been reported 
[51], RES treatment during ischemia in intact hearts involved 
scavenging or inhibiting 𝑂2
•− /ONOO−, with a subsequently decreased 
mitochondrial protein tyr-N, has not been reported. 
We report here for the first time that RES treatment partially 
inhibited DHE fluorescence (emission of 𝑂2
•−) induced during ischemia, 
and abolished it during reperfusion in intact perfused hearts, as well as 
reduced mitochondrial protein tyr-N. Goh et al. [51] reported in 
isolated perfused rat hearts that RES treatment during IR reduced LDH 
release, improved post-ischemic recovery of LV function, and 
increased Akt and p38MAPK activity. In our study, we also found that 
RES, given just before ischemia and present in hearts during ischemia, 
improved cardiac function after IR, which is consistent with the report 
of Goh et al. [51]. In addition, our in vitro experiments with rVDAC 
showed that RES directly, and completely, inhibited tyr-N of rVDAC 
induced by ONOO− while L-NAME did not. Thus, RES is likely an 
inhibitor of 𝑂2
•− emission, and/or a scavenger of ONOO−; it not only 
reduced tyr-N of mitochondrial proteins, specifically VDAC after IR 
injury, but also improved cardiac contractility and relaxation. Although 
RES has been shown to stimulate NOS to generate NO• when given to 
precondition hearts against IR injury [43], it is likely in our 
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experiments that much of NO• produced was converted to ONOO− 
because of abundant 𝑂2
•−, which then leads to nitration of VDAC. 
We have implied that ONOO− is in large part responsible for the 
observed tyr-N and that the major effect of ONOO− is to induce tyr-N. 
Thus, limitations of our study are that ONOO− may induce PTMs of not 
only tyr, but also of other aromatic residues and that tyr may be 
additionally nitrated by non-ONOO− oxidants, such as other nitrites 
and peroxidases. 
In summary, we have identified VDAC as one of the 
mitochondrial proteins that undergoes enhanced tyr-N during IR 
injury. L-NAME and RES likely attenuate VDAC tyr-N in the ex vivo 
model, but only RES abolished ONOO−-induced VDAC nitration in vitro, 
because there was likely no NO• present. Moreover, inhibition of tyr-N 
of VDAC by L-NAME, and especially by RES, not only demonstrates 
that VDAC tyr-N occurs, but also that attenuating ONOO− production 
reduces tyr-N of VDAC and concomitantly improves cardiac function 
after IR. Tyr-N in ONOO−-treated rVDAC is selective and site-specific, 
and was accompanied by rVDAC protein oligomerization. ONOO−-
treated rVDAC also leads to an enhanced channel conductance state. 
The results obtained in this study indicate that VDAC, possibly with 
other unidentified mitochondrial tyr-N proteins, plays a critical role in 
mediating cardiac dysfunction during IR injury. Targeting against 
specific protein tyr-N sites may represent a unique way to protect 
mitochondrial proteins and organs against oxidative damage. 
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ONLINE SUPPLEMENT MATERIAL 
Tyrosine Nitration of Voltage Dependent Anion Channels 
in Cardiac Ischemia-Reperfusion: Reduction by 
Peroxynitrite Scavenging 
 
Meiying Yang, Amadou K.S. Camara, Bassam T. Wakim, Yifan Zhou, 
Ashish K. Gadicherla, Wai-Meng Kwok, David F. Stowe 
 
 
Methods 
 
Isolated heart preparation and protocols 
  
Hearts were prepared for study as described previously [1-4]. 
The investigation was approved by the Medical College of Wisconsin 
Institutional Animal Care and Use Committee. Guinea pigs were given 
heparin (1000 units) and anesthetized with ketamine (50 mg/kg) i.p. 
before sacrifice by decapitation. Hearts were removed and perfused at 
constant pressure (55 mmHg) via the aortic root with an oxygenated 
Krebs-Ringer’s (KR) solution of the following composition (in mmol/L): 
138 Na+, 4.5 K+, 1.2 Mg2+, 2.5 Ca2+, 134 Cl-, 15 HCO3-, 1.2 H2PO4-, 
11.5 glucose, 2 pyruvate, 16 mannitol, 0.1 probenecid, 0.05 EDTA, 
and 5 U/L insulin and gassed with 3% CO2, 97% O2 (pH 7.4) at 37°C. 
Systolic and diastolic left ventricular pressure (LVP) was measured 
isovolumetrically with a transducer connected to a saline-filled latex 
balloon placed in the LV through an incision in the left atrium. Diastolic 
LVP was set to 0 mmHg initially as an increase during IR signifies 
ventricular contracture. Coronary inflow (CF) was measured by an 
ultrasonic flowmeter. Atrial and ventricular bipolar leads were placed 
to measure spontaneous heart rate. The aortic inflow line was clamped 
for 30 min to induce global ischemia. If ventricular fibrillation occurred 
on reperfusion 250 µg of lidocaine was given via the aortic cannula to 
restore sinus rhythm.  
 
At the end of either 30 min ischemia (I), or 10, 30, or 60 min 
reperfusion (R) hearts were removed and mitochondria were 
immediately isolated for proteomic and other molecular studies. In the 
treated groups either 100 µmol/L NG -nitro-L-arginine methyl ester (L-
NAME) or 10 µmol/L resveratrol (RES) was perfused for 10 min up to 
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the initiation of global ischemia so that the drug remained in the heart 
during ischemia. These concentrations were chosen because 10 µmol/L 
of RES was reported to be cardioprotective in isolated rat hearts [5] 
and 100 µmol/L of L-NAME blocked ONOO− production in cold (17°C) 
perfused isolated hearts [2]. 
 
 
 
Detection of 𝑂2
•− in isolated hearts loaded with DHE 
  
Intracellular fluorescent probe dihydroethidium (DHE) 
(Molecular Probes) was used to assess 𝑂2
•−  emission in the isolated 
heart during IR. DHE is readily taken up by cells, and oxidized by 𝑂2
•−  
[6] to form 2-hydoxyethidium (2-OH-E+) and ethidium (Eth) [7]. 2-
OH-E+ is labile and the source of the variable fluorescence at the 
emission wavelength of 590 nm (λem 590) when excited at 540 nm (λex 
540) [7]. DHE and its derivatives are retained within cells with minimal 
leakage [8]. 
 
This method for detecting 𝑂2
•−  with DHE in intact beating hearts 
has been described by us previously [1-3, 9]. Isolated hearts are 
perfused in a light-blocking Faraday cage. The distal end of a 
trifurcated fiber-optic cable (optical surface area 3.85 mm2) is placed 
against the LV free wall through an “O” ring-tightly sealed hole in the 
tissue bath. Nylon netting is gently applied around the heart for 
optimal contact with the fiber optic probe without impeding relaxation. 
The fiber-optic cable is connected to a modified fluorescence 
spectrophotometer (Photon Technology International, or SLM Aminco-
Bowman II, Spectronic Instruments). Fluorescent emissions are 
amplified by a photomultiplier tube (PMT) (700 V applied) and 
recorded after excitation with a 150 W xenon arc lamp. The excitation 
wavelength penetrates the thickness (4–5 mm) of the LV free wall. 
Signals are recorded continuously during the entire experiment. 
 
After attaining stability, hearts were loaded with 10 µmol/L of 
DHE in KR solution for 20 min, followed by washout of residual DHE 
with KR solution for another 20 min. DHE loaded hearts were treated 
with/without RES/L-NAME before ischemia, followed by IR. DHE dye 
loading increases fluorescence intensity from 0.3 ±0.01 arbitrary 
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fluorescence units (afu) before dye loading to 2.2 ±0.2 afu after 
washout of residual dye. The final DHE value after washout was 
adjusted to 0 afu (baseline) to normalize the fluorescence intensity for 
all experiments. Changes in DHE fluorescence signal, which represents 
𝑂2
•−  generation, were compared to the baseline fluorescence signal 
value. 
  
 
Detection of ONOO− in isolated hearts loaded with L-tyrosine. 
 
We have described in detail how to indirectly detect ONOO− in 
isolated hearts [2]. In brief, dityrosine (DiTyr) fluorescence is used to 
measure ONOO− formation using the same fiberoptic probe as for DHE 
fluorescence. ONOO−, a product of 𝑂2
•−  and NO•, reacts with perfused 
L-tyrosine to form the fluorescent dimer, DiTyr [10]. The reaction of L-
tyrosine with ONOO− to produce DiTyr fluorescence occurs 
immediately, and the product is stable at tissue pH [11]. L-tyrosine 
(0.3 mmol/L) is added to the KR buffer, and unlike DHE, is present 
throughout the experiment. Signal intensity is recorded continuously 
at spectra λex 320 nm and λem 410 nm.  
  
Fig. S1. Representative SDS-PAGE gel of anti-3-NT 
immunoprecipitates from IR group. All immunoprecipitates were first 
loaded into the loading wells, and then the gel was run at 150 V. After 
all samples entered the separating gel part of SDS-PAGE gel, the gel 
was run for an additional 5 min and then silver stained. Lane 1: anti-3-
NT immunoprecipitates; Lane 2: Marker; Part 1 and Part 2: collected 
samples for LC-MS/MS assay.  
 
Fig. S2. Assessment of VDAC and tyr-N of VADC spots on 2-DE gel. 
Mitochondrial proteins from TC and IR10 groups were subjected to 2-
DE followed by Western blot with anti-3-NT antibody (A, B). After 
probing with anti-3-NT, the membranes were stripped and reprobed 
with VDAC antibody (C, D).  Solid tilted arrows indicate the VDAC 
positions. pH positions were determined according to the 
manufacturer’s guide. WB: Western blot. 
 
Fig. S3. 2-DE gel of rVDAC and rVDAC incubated with ONOO−. rVDAC 
incubated without (control) or with 200 µmol/L ONOO− were subjected 
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to 2-DE followed by Western blotting with anti-3-NT antibody (A, B). 
After that the membranes were stripped and then blotted with anti-
VDAC antibody (C, D). pH positions were determined according to the 
manufacturer’s guide. WB: Western blot. 
 
Fig. S4. Characteristics voltage-dependence of rVDAC and native 
VDAC in response to a ramp voltage protocol from -80 to +80 mV 
under control conditions. rVDAC or native VDAC protein was added 
into the cis chamber. After one channel was inserted into the planar 
lipid bilayers, currents were recorded under voltage-clamp using a 
voltage clamp amplifier (Axopatch 200B, Molecular Devices) and 
recorded in 1 min segments. 
 
Table S1. Proteins identified in anti-3-NT immunoprecipitates with LC-MS/MS. 
 
 
 
 
Sequence information from the LC-MS/MS data was analyzed using Visualize software 
(Brian Halligan, Medical College of Wisconsin). Protein Probability (Protein Probability 
of 1 means 100%) and False Discovery Rate (FDR) were calculated automatically 
using this program. All identified proteins met FDR less than 1.5%. Accession numbers 
are quoted from Apropos, UniportKB/Swiss-port and PubMed. Band number refers to 
the gel cut from Fig. S1. 
 
Table S2. The full length of rat VDAC amino acids sequence. 
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Residues in bold italic represented amino acids determined by our MALDI-TOF MS 
analysis. Underlined residues represent a peptide fragment containing tyr-N residues 
with a predicted mass of m/z 1693. * indicates the specific tyr-N residues. 
 
Table S3. Cardiac function in time control (TC) non-ischemic, non treated group 
over time. 
 
Perfusion times 30 and 50 min are equivalent to 10 and 30 min ischemia and 60 min 
reperfusion is equivalent to 10 min reperfusion after ischemia (see Table 1, Fig. 1). 
Values are means ±SEM. sys-dia LVP: systolic-diastolic left ventricular pressure; 
dLVP/dtmax: index of contractility; dLVP/dtmin: index of relaxation; N = 10 hearts; 
average values for each variable did not change over time. 
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𝑂2
•− superoxide 
NO• nitric oxide 
ONOO− peroxynitrite 
tyr tyrosine 
tyr-N tyrosine nitration 
IR ischemia reperfusion 
IP immunoprecipitation 
VDAC voltage-dependent anion channel 
RES resveratrol 
RNS reactive nitrogen species 
L-NAME NG nitro-L-arginine methyl ester 
PTM post translational modifications 
ROS reactive oxygen species 
ETC electron transport chain 
3-NT 3-nitrotyrosine 
DHE dihydroethidium 
DiTyr dityrosine 
LVP left ventricular pressure 
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PLB planar lipid bilayers 
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✩Footnotes: Preliminary reports of this work: FASEB J LB589, 2010; FASEB J 
639.14, 2011; FASEB J 678.19, 2012. 
Disclosures 
None. 
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Supplementary data to this article can be found online at 
http://dx.doi.org/10.1016/j.bbabio.2012.06.004. 
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